Christopher J.B. Nicol

4.8k total citations · 1 hit paper
75 papers, 4.0k citations indexed

About

Christopher J.B. Nicol is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Christopher J.B. Nicol has authored 75 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 19 papers in Physiology and 14 papers in Cancer Research. Recurrent topics in Christopher J.B. Nicol's work include Peroxisome Proliferator-Activated Receptors (25 papers), Metabolism, Diabetes, and Cancer (10 papers) and Adipose Tissue and Metabolism (10 papers). Christopher J.B. Nicol is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (25 papers), Metabolism, Diabetes, and Cancer (10 papers) and Adipose Tissue and Metabolism (10 papers). Christopher J.B. Nicol collaborates with scholars based in Canada, United States and Taiwan. Christopher J.B. Nicol's co-authors include Frank J. Gonzalez, Peter G. Wells, Ming‐Chang Chiang, Kimihiko Matsusue, Rebecca R. Laposa, Taro E. Akiyama, Jerrold M. Ward, Yi‐Chuan Cheng, Lisa K. Johnson and Kelly R. Dietz and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Christopher J.B. Nicol

74 papers receiving 4.0k citations

Hit Papers

Liver Peroxisome Proliferator-activated Receptor γ Contri... 2003 2026 2010 2018 2003 200 400 600

Peers

Christopher J.B. Nicol
Christopher J.B. Nicol
Citations per year, relative to Christopher J.B. Nicol Christopher J.B. Nicol (= 1×) peers Filomena de Nigris

Countries citing papers authored by Christopher J.B. Nicol

Since Specialization
Citations

This map shows the geographic impact of Christopher J.B. Nicol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J.B. Nicol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J.B. Nicol more than expected).

Fields of papers citing papers by Christopher J.B. Nicol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J.B. Nicol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J.B. Nicol. The network helps show where Christopher J.B. Nicol may publish in the future.

Co-authorship network of co-authors of Christopher J.B. Nicol

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J.B. Nicol. A scholar is included among the top collaborators of Christopher J.B. Nicol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J.B. Nicol. Christopher J.B. Nicol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Tony F., Yuping Yang, Christopher J.B. Nicol, T M Chiang, & Chiahui Yen. (2025). Resveratrol-Enhanced Human Neural Stem Cell-Derived Exosomes Mitigate MPP+-Induced Neurotoxicity Through Activation of AMPK and Nrf2 Pathways and Inhibition of the NLRP3 Inflammasome in SH-SY5Y Cells. Life. 15(2). 294–294. 4 indexed citations
2.
Chiang, Ming‐Chang, Christopher J.B. Nicol, Yuping Yang, T M Chiang, & Chiahui Yen. (2025). The α-MG exhibits neuroprotective potential by reducing amyloid beta peptide-induced inflammation, oxidative stress, and tau aggregation in human neural stem cells. Brain Research. 1852. 149506–149506. 3 indexed citations
3.
Chiang, Ming‐Chang, et al.. (2024). Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection. International Journal of Molecular Sciences. 25(4). 2360–2360. 44 indexed citations
4.
Nicol, Christopher J.B., et al.. (2024). A Novel Bioluminescent Biosensor Quantifying Intramolecular Interaction and Levels of Pyroptosis Effector GSDMD. Cells. 13(19). 1606–1606. 2 indexed citations
5.
Hao, Yawei, et al.. (2024). Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer. International Journal of Molecular Sciences. 25(7). 4064–4064. 2 indexed citations
6.
Kaufmann, Martin, David Hurlbut, John F. Rudan, et al.. (2023). Metabolically Active Zones Involving Fatty Acid Elongation Delineated by DESI-MSI Correlate with Pathological and Prognostic Features of Colorectal Cancer. Metabolites. 13(4). 508–508. 6 indexed citations
7.
Kaufmann, Martin, Gábor Fichtinger, Parvin Mousavi, et al.. (2023). Molecular characterization of human peripheral nerves using desorption electrospray ionization mass spectrometry imaging. Journal of Anatomy. 243(5). 758–769. 2 indexed citations
8.
Choi, Jihoon, et al.. (2022). Novel MicroRNA-Regulated Transcript Networks Are Associated with Chemotherapy Response in Ovarian Cancer. International Journal of Molecular Sciences. 23(9). 4875–4875. 3 indexed citations
9.
Ghaffari, Abdi, Sandip Sengupta, Yolanda Madarnas, et al.. (2022). Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis. Cancer Research Communications. 2(6). 456–470. 5 indexed citations
10.
Nicol, Christopher J.B., et al.. (2019). Examining the Role of Nuclear Receptors During In Vivo Chemical-Mediated Breast Tumorigenesis. Methods in molecular biology. 1966. 203–210. 1 indexed citations
11.
Craig, Andrew W., et al.. (2019). A PKA/cdc42 Signaling Axis Restricts Angiogenic Sprouting by Regulating Podosome Rosette Biogenesis and Matrix Remodeling. Scientific Reports. 9(1). 2385–2385. 11 indexed citations
12.
Lightbody, Elizabeth D. & Christopher J.B. Nicol. (2019). Immunofluorescence Labeling of Nuclear Receptor Expression in Formalin-Fixed, Paraffin-Embedded Tissue. Methods in molecular biology. 1966. 101–105. 3 indexed citations
13.
Zhao, Yulei, Taha Azad, Elizabeth D. Lightbody, et al.. (2018). PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways. Molecular Cancer Research. 16(6). 1046–1058. 56 indexed citations
14.
Lin, Chien‐Hung, Yi‐Chuan Cheng, Christopher J.B. Nicol, et al.. (2017). Activation of AMPK is neuroprotective in the oxidative stress by advanced glycosylation end products in human neural stem cells. Experimental Cell Research. 359(2). 367–373. 41 indexed citations
15.
Körschen, Heinz G., et al.. (2016). A Fluorometric Activity Assay for Light-Regulated Cyclic-Nucleotide-Monophosphate Actuators. Methods in molecular biology. 1408. 93–105. 3 indexed citations
16.
Roche, Jennifer M., et al.. (2015). Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression. Molecular Cancer. 14(1). 85–85. 23 indexed citations
17.
Chen, Yen‐Lin, Dee Pei, Yi‐Chuan Cheng, et al.. (2015). The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(5). 720–731. 71 indexed citations
18.
Wells, Peter G., Chao Chen, Winnie Jeng, et al.. (2005). Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicology and Applied Pharmacology. 207(2). 354–366. 180 indexed citations
19.
Crosby, Michelle B., John H. Zhang, John L. Svenson, et al.. (2005). Inflammatory modulation of PPARγ expression and activity. Clinical Immunology. 118(2-3). 276–283. 18 indexed citations
20.
Wells, Peter G., et al.. (1997). Oxidative damage in chemical teratogenesis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 396(1-2). 65–78. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026